1887

Abstract

SUMMARY

The mechanism of interferon resistance was studied in two clones of Daudi cells, DIF and DIF, which exhibit respectively moderate and pronounced resistance to both the antiviral and antiproliferative actions of human interferons-α and -β. Clones DIF and DIF were found to possess specific high affinity interferon receptors similar to those of parental Daudi cells. However, DIF cells, which have a tetraploid karyotype, had approximately twice as many interferon-binding sites as either DIF or parental Daudi cells. One of the first detectable changes in Daudi cells following interferon treatment is a rapid increase in the intracellular concentration of cyclic GMP. No increase in cyclic GMP was observed in DIF or DIF cells treated with interferon-α. However, neither DIF nor DIF cells respond to sodium azide, a non-physiological inducer of cyclic GMP. Interferon treatment was found to induce the production of 2′-5′-oligo-isoadenylate synthetase in DIF and DIF cells in a manner similar to parental Daudi cells, indicating that these cells possess functional interferon receptors. The levels of 2′-5′-oligo-isoadenylate synthetase and 2′-5′ A phosphodiesterase activity were similar in all three cell lines, suggesting that the interferon resistance of clones DIF and DIF was not due to a deficiency of pp(A2′ p)A.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-12-2649
1983-12-01
2021-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/12/JV0640122649.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-12-2649&mimeType=html&fmt=ahah

References

  1. Aguet M. 1980; High-affinity binding of125 I-labelled mouse interferon to a specific cell surface receptor. Nature, London 284:459–461
    [Google Scholar]
  2. Aguet M., Blanchard B. 1981; High affinity binding of l25I-labelled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties. Virology 115:249–261
    [Google Scholar]
  3. Dron M., Tovey M. G. 1983; Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization. Journal of General Virology 64:2641–2647
    [Google Scholar]
  4. Epstein C. J., Mcmanus N. H., Epstein L. B., Branca A. A., D’alessandro S. B., Baglioni C. 1982; Direct evidence that the gene product of the human chromosome 21 locus IFRC, is the interferon α receptor. Biochemical and Biophysical Research Communications 107:1060–1066
    [Google Scholar]
  5. Kerr I. M., Wreschner D. H., Silverman R. H., Cayley P. J., Knight M. 1981; The 2–5A (pppA2′p5′A2′p5′A) and protein kinase systems in interferon-treated and control cells. In Advances in Cyclic Nucleotide Research vol 14: pp 469–478 Edited by Dumont J. E., Greengard P., Robison G. A. New York: Raven Press;
    [Google Scholar]
  6. Krishnan I., Baglioni C. 1980; Increased levels of (2′–5′) oligo(A) polymerase activity in human lympho- blastoid cells treated with glycocorticoids. Proceedings of the National Academy of Sciences, U. S. A 77:6506–6510
    [Google Scholar]
  7. Lebleu B., Content J. 1982; Mechanisms of interferon action: biochemical and genetic approaches. In Interferon 4, 1982 pp 47–94 Edited by Gresser I. London: Academic Press;
    [Google Scholar]
  8. Lengyel P. 1981; Mechanisms of interferon action: the (2′–5′)(A), synthetase-RNase L pathway. In Interferon 3, 1981 pp 78–99 Edited by Gresser I. London: Academic Press;
    [Google Scholar]
  9. Merlin G., Revel M., Wallach D. 1981; The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products. Analytical Biochemistry 110:190–196
    [Google Scholar]
  10. Mogensen K. E., Bandu M.-T. 1983; Kinetic evidence for an activation step following binding of human interferon α2 to the membrane receptors of Daudi cells. European Journal of Biochemistry (in press)
    [Google Scholar]
  11. Mogensen K. E., Bandu M.-T., Vignaux F., Aguet M., Gresser I. 1981; Binding of 125I-labelled human α interferon to human lymphoid cells. International Journal of Cancer 28:575–582
    [Google Scholar]
  12. Mogensen K. E., Vignaux F., Gresser I. 1982; Enhanced expression of cellular receptors for human interferon- a on peripheral lymphocytes from patients with Down’s syndrome. FEBS Letters 140:285–287
    [Google Scholar]
  13. Murad F., Manganello V., Vaughn M. 1971; A simple sensitive protein-binding assay for guanosine 3′–5′- monophosphate. Proceedings of the National Academy of Sciences U. S. A 68:736–739
    [Google Scholar]
  14. Rochette-Egly C., Castagna M. 1977; A simultaneous protein-binding assay for adenosine 3–5′- monophosphate and guanosine 3 –5-monophosphate in biological materials. Biochemical and Biophysical Research Communications 74:1287–1296
    [Google Scholar]
  15. Scatchard G. 1949; The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 51:660–672
    [Google Scholar]
  16. Silverman R. H., Watling D., Balkwill F. R., Trowsdale J., Kerr I. M. 1982; The ppp(A2’p)., A and protein kinase systems in wild-type and interferon resistant Daudi cells. European Journal of Biochemistry 126:333–341
    [Google Scholar]
  17. Tomita Y., Cantell K., Kuwata T. 1982; Effects of human γ interferon on cell growth, replication of virus and induction of 2 –5′ oligoadenylate synthetase in three human lymphoblastoid cell lines and K652 cells. International Journal of Cancer 30:161–165
    [Google Scholar]
  18. Tovey M. G. 1982; Interferon and cyclic nucleotides. In Interferon 4, 1982 pp 23–46 Edited by Gresser I. London: Academic Press;
    [Google Scholar]
  19. Tovey M. G., Rochette-Egly C. 1981; Rapid increase in guanosine 3 –5′ cyclic-monophosphate in interferon- treated mouse leukemia LI210 cells: relationship to the development of the antiviral state and inhibition of cell multiplication. Virology 115:272–281
    [Google Scholar]
  20. Tovey M. G., Rochette-Egly C., Castagna M. 1979; Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proceedings of the National Academy of Sciences, U. S. A 76:3890–3893
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-12-2649
Loading
/content/journal/jgv/10.1099/0022-1317-64-12-2649
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error